Therapeutic Vaccines Industry Research Report 2025
Description
Summary
According to APO Research, the global Therapeutic Vaccines market was valued at US$ million in 2024 and is anticipated to reach US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2025-2031.
North American market for Therapeutic Vaccines is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Therapeutic Vaccines is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Therapeutic Vaccines is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Therapeutic Vaccines include Agenus, AVAX Technologies, CIMAB S.A, Corixa, Dendreon, Northeast Biotherapeutics and Vaccinogen Inc, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Therapeutic Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Therapeutic Vaccines.
The report will help the Therapeutic Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
The Therapeutic Vaccines market size, estimations, and forecasts are provided in terms of sales volume (k units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Therapeutic Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.
Therapeutic Vaccines Segment by Company
Agenus AVAX Technologies CIMAB S.A Corixa Dendreon Northeast Biotherapeutics Vaccinogen IncTherapeutic Vaccines Segment by Type
Nucleic Acid Therapeutic Vaccine Peptide Therapeutic Vaccine Cell Therapeutic VaccineTherapeutic Vaccines Segment by Application
Oncotherapy Hepatitis B Tuberculosis Herpes Simplex Virus OthersTherapeutic Vaccines Segment by Region
North America United States Canada Europe Germany France U.K. Italy Netherlands Asia-Pacific China Japan South Korea India Australia China Taiwan Southeast Asia South America Mexico Brazil Argentina Colombia Middle East & Africa Turkey Saudi Arabia UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Therapeutic Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Therapeutic Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Therapeutic Vaccines.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Therapeutic Vaccines manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Therapeutic Vaccines by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Therapeutic Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
According to APO Research, the global Therapeutic Vaccines market was valued at US$ million in 2024 and is anticipated to reach US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2025-2031.
North American market for Therapeutic Vaccines is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Therapeutic Vaccines is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Therapeutic Vaccines is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Therapeutic Vaccines include Agenus, AVAX Technologies, CIMAB S.A, Corixa, Dendreon, Northeast Biotherapeutics and Vaccinogen Inc, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Therapeutic Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Therapeutic Vaccines.
The report will help the Therapeutic Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
The Therapeutic Vaccines market size, estimations, and forecasts are provided in terms of sales volume (k units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Therapeutic Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.
Therapeutic Vaccines Segment by Company
Agenus AVAX Technologies CIMAB S.A Corixa Dendreon Northeast Biotherapeutics Vaccinogen IncTherapeutic Vaccines Segment by Type
Nucleic Acid Therapeutic Vaccine Peptide Therapeutic Vaccine Cell Therapeutic VaccineTherapeutic Vaccines Segment by Application
Oncotherapy Hepatitis B Tuberculosis Herpes Simplex Virus OthersTherapeutic Vaccines Segment by Region
North America United States Canada Europe Germany France U.K. Italy Netherlands Asia-Pacific China Japan South Korea India Australia China Taiwan Southeast Asia South America Mexico Brazil Argentina Colombia Middle East & Africa Turkey Saudi Arabia UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Therapeutic Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Therapeutic Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Therapeutic Vaccines.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Therapeutic Vaccines manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Therapeutic Vaccines by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Therapeutic Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
Table of Contents
120 Pages
- 1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
- 2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Therapeutic Vaccines Market Size (2020-2031)
- 2.2.2 Global Therapeutic Vaccines Sales (2020-2031)
- 2.2.3 Global Therapeutic Vaccines Market Average Price (2020-2031)
- 2.3 Therapeutic Vaccines by Type
- 2.3.1 Market Value Comparison by Type (2020 VS 2024 VS 2031) & (US$ Million)
- 2.3.2 Nucleic Acid Therapeutic Vaccine
- 2.3.3 Peptide Therapeutic Vaccine
- 2.3.4 Cell Therapeutic Vaccine
- 2.4 Therapeutic Vaccines by Application
- 2.4.1 Market Value Comparison by Application (2020 VS 2024 VS 2031)
- 2.4.2 Oncotherapy
- 2.4.3 Hepatitis B
- 2.4.4 Tuberculosis
- 2.4.5 Herpes Simplex Virus
- 2.4.6 Others
- 3 Market Competitive Landscape by Manufacturers
- 3.1 Global Therapeutic Vaccines Market Competitive Situation by Manufacturers (2020 Versus 2024)
- 3.2 Global Therapeutic Vaccines Sales (k units) of Manufacturers (2020-2025)
- 3.3 Global Therapeutic Vaccines Revenue of Manufacturers (2020-2025)
- 3.4 Global Therapeutic Vaccines Average Price by Manufacturers (2020-2025)
- 3.5 Global Therapeutic Vaccines Industry Ranking, 2023 VS 2024 VS 2025
- 3.6 Global Manufacturers of Therapeutic Vaccines, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Therapeutic Vaccines, Product Type & Application
- 3.8 Global Manufacturers of Therapeutic Vaccines, Established Date
- 3.9 Global Therapeutic Vaccines Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
- 4 Manufacturers Profiled
- 4.1 Agenus
- 4.1.1 Agenus Company Information
- 4.1.2 Agenus Business Overview
- 4.1.3 Agenus Therapeutic Vaccines Sales, Revenue and Gross Margin (2020-2025)
- 4.1.4 Agenus Therapeutic Vaccines Product Portfolio
- 4.1.5 Agenus Recent Developments
- 4.2 AVAX Technologies
- 4.2.1 AVAX Technologies Company Information
- 4.2.2 AVAX Technologies Business Overview
- 4.2.3 AVAX Technologies Therapeutic Vaccines Sales, Revenue and Gross Margin (2020-2025)
- 4.2.4 AVAX Technologies Therapeutic Vaccines Product Portfolio
- 4.2.5 AVAX Technologies Recent Developments
- 4.3 CIMAB S.A
- 4.3.1 CIMAB S.A Company Information
- 4.3.2 CIMAB S.A Business Overview
- 4.3.3 CIMAB S.A Therapeutic Vaccines Sales, Revenue and Gross Margin (2020-2025)
- 4.3.4 CIMAB S.A Therapeutic Vaccines Product Portfolio
- 4.3.5 CIMAB S.A Recent Developments
- 4.4 Corixa
- 4.4.1 Corixa Company Information
- 4.4.2 Corixa Business Overview
- 4.4.3 Corixa Therapeutic Vaccines Sales, Revenue and Gross Margin (2020-2025)
- 4.4.4 Corixa Therapeutic Vaccines Product Portfolio
- 4.4.5 Corixa Recent Developments
- 4.5 Dendreon
- 4.5.1 Dendreon Company Information
- 4.5.2 Dendreon Business Overview
- 4.5.3 Dendreon Therapeutic Vaccines Sales, Revenue and Gross Margin (2020-2025)
- 4.5.4 Dendreon Therapeutic Vaccines Product Portfolio
- 4.5.5 Dendreon Recent Developments
- 4.6 Northeast Biotherapeutics
- 4.6.1 Northeast Biotherapeutics Company Information
- 4.6.2 Northeast Biotherapeutics Business Overview
- 4.6.3 Northeast Biotherapeutics Therapeutic Vaccines Sales, Revenue and Gross Margin (2020-2025)
- 4.6.4 Northeast Biotherapeutics Therapeutic Vaccines Product Portfolio
- 4.6.5 Northeast Biotherapeutics Recent Developments
- 4.7 Vaccinogen Inc
- 4.7.1 Vaccinogen Inc Company Information
- 4.7.2 Vaccinogen Inc Business Overview
- 4.7.3 Vaccinogen Inc Therapeutic Vaccines Sales, Revenue and Gross Margin (2020-2025)
- 4.7.4 Vaccinogen Inc Therapeutic Vaccines Product Portfolio
- 4.7.5 Vaccinogen Inc Recent Developments
- 5 Global Therapeutic Vaccines Market Scenario by Region
- 5.1 Global Therapeutic Vaccines Market Size by Region: 2020 VS 2024 VS 2031
- 5.2 Global Therapeutic Vaccines Sales by Region: 2020-2031
- 5.2.1 Global Therapeutic Vaccines Sales by Region: 2020-2025
- 5.2.2 Global Therapeutic Vaccines Sales by Region: 2026-2031
- 5.3 Global Therapeutic Vaccines Revenue by Region: 2020-2031
- 5.3.1 Global Therapeutic Vaccines Revenue by Region: 2020-2025
- 5.3.2 Global Therapeutic Vaccines Revenue by Region: 2026-2031
- 5.4 North America Therapeutic Vaccines Market Facts & Figures by Country
- 5.4.1 North America Therapeutic Vaccines Market Size by Country: 2020 VS 2024 VS 2031
- 5.4.2 North America Therapeutic Vaccines Sales by Country (2020-2031)
- 5.4.3 North America Therapeutic Vaccines Revenue by Country (2020-2031)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Therapeutic Vaccines Market Facts & Figures by Country
- 5.5.1 Europe Therapeutic Vaccines Market Size by Country: 2020 VS 2024 VS 2031
- 5.5.2 Europe Therapeutic Vaccines Sales by Country (2020-2031)
- 5.5.3 Europe Therapeutic Vaccines Revenue by Country (2020-2031)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Therapeutic Vaccines Market Facts & Figures by Country
- 5.6.1 Asia Pacific Therapeutic Vaccines Market Size by Country: 2020 VS 2024 VS 2031
- 5.6.2 Asia Pacific Therapeutic Vaccines Sales by Country (2020-2031)
- 5.6.3 Asia Pacific Therapeutic Vaccines Revenue by Country (2020-2031)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Therapeutic Vaccines Market Facts & Figures by Country
- 5.7.1 South America Therapeutic Vaccines Market Size by Country: 2020 VS 2024 VS 2031
- 5.7.2 South America Therapeutic Vaccines Sales by Country (2020-2031)
- 5.7.3 South America Therapeutic Vaccines Revenue by Country (2020-2031)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.7.7 Colombia
- 5.8 Middle East and Africa Therapeutic Vaccines Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Therapeutic Vaccines Market Size by Country: 2020 VS 2024 VS 2031
- 5.8.2 Middle East and Africa Therapeutic Vaccines Sales by Country (2020-2031)
- 5.8.3 Middle East and Africa Therapeutic Vaccines Revenue by Country (2020-2031)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
- 6 Segment by Type
- 6.1 Global Therapeutic Vaccines Sales by Type (2020-2031)
- 6.1.1 Global Therapeutic Vaccines Sales by Type (2020-2031) & (k units)
- 6.1.2 Global Therapeutic Vaccines Sales Market Share by Type (2020-2031)
- 6.2 Global Therapeutic Vaccines Revenue by Type (2020-2031)
- 6.2.1 Global Therapeutic Vaccines Sales by Type (2020-2031) & (US$ Million)
- 6.2.2 Global Therapeutic Vaccines Revenue Market Share by Type (2020-2031)
- 6.3 Global Therapeutic Vaccines Price by Type (2020-2031)
- 7 Segment by Application
- 7.1 Global Therapeutic Vaccines Sales by Application (2020-2031)
- 7.1.1 Global Therapeutic Vaccines Sales by Application (2020-2031) & (k units)
- 7.1.2 Global Therapeutic Vaccines Sales Market Share by Application (2020-2031)
- 7.2 Global Therapeutic Vaccines Revenue by Application (2020-2031)
- 7.2.1 Global Therapeutic Vaccines Sales by Application (2020-2031) & (US$ Million)
- 7.2.2 Global Therapeutic Vaccines Revenue Market Share by Application (2020-2031)
- 7.3 Global Therapeutic Vaccines Price by Application (2020-2031)
- 8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Therapeutic Vaccines Value Chain Analysis
- 8.1.1 Therapeutic Vaccines Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Therapeutic Vaccines Production Mode & Process
- 8.2 Therapeutic Vaccines Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Therapeutic Vaccines Distributors
- 8.2.3 Therapeutic Vaccines Customers
- 9 Global Therapeutic Vaccines Analyzing Market Dynamics
- 9.1 Therapeutic Vaccines Industry Trends
- 9.2 Therapeutic Vaccines Industry Drivers
- 9.3 Therapeutic Vaccines Industry Opportunities and Challenges
- 9.4 Therapeutic Vaccines Industry Restraints
- 10 Report Conclusion
- 11 Disclaimer
- List of Tables
- Table 1. Secondary Sources
- Table 2. Primary Sources
- Table 3. Market Value Comparison by Type (2020 VS 2024 VS 2031) & (US$ Million)
- Table 4. Market Value Comparison by Application (2020 VS 2024 VS 2031) & (US$ Million)
- Table 5. Global Therapeutic Vaccines Volume and Revenue Market Size and CAGR of Manufacturers (2020 Versus 2024)
- Table 6. Global Therapeutic Vaccines Sales (k units) of Manufacturers (2020-2025)
- Table 7. Global Therapeutic Vaccines Sales Market Share by Manufacturers (2020-2025)
- Table 8. Global Therapeutic Vaccines Revenue of Manufacturers (2020-2025)
- Table 9. Global Therapeutic Vaccines Revenue Share by Manufacturers (2020-2025)
- Table 10. Global Market Therapeutic Vaccines Average Price (US$/unit) of Manufacturers (2020-2025)
- Table 11. Global Therapeutic Vaccines Industry Ranking, 2023 VS 2024 VS 2025
- Table 12. Global Manufacturers of Therapeutic Vaccines, Manufacturing Sites & Headquarters
- Table 13. Global Manufacturers of Therapeutic Vaccines, Product Type & Application
- Table 14. Global Therapeutic Vaccines Manufacturers Established Date
- Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
- Table 16. Global Therapeutic Vaccines by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2024)
- Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans)
- Table 18. Agenus Company Information
- Table 19. Agenus Business Overview
- Table 20. Agenus Therapeutic Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2020-2025)
- Table 21. Agenus Therapeutic Vaccines Product Portfolio
- Table 22. Agenus Recent Developments
- Table 23. AVAX Technologies Company Information
- Table 24. AVAX Technologies Business Overview
- Table 25. AVAX Technologies Therapeutic Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2020-2025)
- Table 26. AVAX Technologies Therapeutic Vaccines Product Portfolio
- Table 27. AVAX Technologies Recent Developments
- Table 28. CIMAB S.A Company Information
- Table 29. CIMAB S.A Business Overview
- Table 30. CIMAB S.A Therapeutic Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2020-2025)
- Table 31. CIMAB S.A Therapeutic Vaccines Product Portfolio
- Table 32. CIMAB S.A Recent Developments
- Table 33. Corixa Company Information
- Table 34. Corixa Business Overview
- Table 35. Corixa Therapeutic Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2020-2025)
- Table 36. Corixa Therapeutic Vaccines Product Portfolio
- Table 37. Corixa Recent Developments
- Table 38. Dendreon Company Information
- Table 39. Dendreon Business Overview
- Table 40. Dendreon Therapeutic Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2020-2025)
- Table 41. Dendreon Therapeutic Vaccines Product Portfolio
- Table 42. Dendreon Recent Developments
- Table 43. Northeast Biotherapeutics Company Information
- Table 44. Northeast Biotherapeutics Business Overview
- Table 45. Northeast Biotherapeutics Therapeutic Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2020-2025)
- Table 46. Northeast Biotherapeutics Therapeutic Vaccines Product Portfolio
- Table 47. Northeast Biotherapeutics Recent Developments
- Table 48. Vaccinogen Inc Company Information
- Table 49. Vaccinogen Inc Business Overview
- Table 50. Vaccinogen Inc Therapeutic Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2020-2025)
- Table 51. Vaccinogen Inc Therapeutic Vaccines Product Portfolio
- Table 52. Vaccinogen Inc Recent Developments
- Table 53. Global Therapeutic Vaccines Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
- Table 54. Global Therapeutic Vaccines Sales by Region (2020-2025) & (k units)
- Table 55. Global Therapeutic Vaccines Sales Market Share by Region (2020-2025)
- Table 56. Global Therapeutic Vaccines Sales by Region (2026-2031) & (k units)
- Table 57. Global Therapeutic Vaccines Sales Market Share by Region (2026-2031)
- Table 58. Global Therapeutic Vaccines Revenue by Region (2020-2025) & (US$ Million)
- Table 59. Global Therapeutic Vaccines Revenue Market Share by Region (2020-2025)
- Table 60. Global Therapeutic Vaccines Revenue by Region (2026-2031) & (US$ Million)
- Table 61. Global Therapeutic Vaccines Revenue Market Share by Region (2026-2031)
- Table 62. North America Therapeutic Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
- Table 63. North America Therapeutic Vaccines Sales by Country (2020-2025) & (k units)
- Table 64. North America Therapeutic Vaccines Sales by Country (2026-2031) & (k units)
- Table 65. North America Therapeutic Vaccines Revenue by Country (2020-2025) & (US$ Million)
- Table 66. North America Therapeutic Vaccines Revenue by Country (2026-2031) & (US$ Million)
- Table 67. Europe Therapeutic Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
- Table 68. Europe Therapeutic Vaccines Sales by Country (2020-2025) & (k units)
- Table 69. Europe Therapeutic Vaccines Sales by Country (2026-2031) & (k units)
- Table 70. Europe Therapeutic Vaccines Revenue by Country (2020-2025) & (US$ Million)
- Table 71. Europe Therapeutic Vaccines Revenue by Country (2026-2031) & (US$ Million)
- Table 72. Asia Pacific Therapeutic Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
- Table 73. Asia Pacific Therapeutic Vaccines Sales by Country (2020-2025) & (k units)
- Table 74. Asia Pacific Therapeutic Vaccines Sales by Country (2026-2031) & (k units)
- Table 75. Asia Pacific Therapeutic Vaccines Revenue by Country (2020-2025) & (US$ Million)
- Table 76. Asia Pacific Therapeutic Vaccines Revenue by Country (2026-2031) & (US$ Million)
- Table 77. South America Therapeutic Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
- Table 78. South America Therapeutic Vaccines Sales by Country (2020-2025) & (k units)
- Table 79. South America Therapeutic Vaccines Sales by Country (2026-2031) & (k units)
- Table 80. South America Therapeutic Vaccines Revenue by Country (2020-2025) & (US$ Million)
- Table 81. South America Therapeutic Vaccines Revenue by Country (2026-2031) & (US$ Million)
- Table 82. Middle East and Africa Therapeutic Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
- Table 83. Middle East and Africa Therapeutic Vaccines Sales by Country (2020-2025) & (k units)
- Table 84. Middle East and Africa Therapeutic Vaccines Sales by Country (2026-2031) & (k units)
- Table 85. Middle East and Africa Therapeutic Vaccines Revenue by Country (2020-2025) & (US$ Million)
- Table 86. Middle East and Africa Therapeutic Vaccines Revenue by Country (2026-2031) & (US$ Million)
- Table 87. Global Therapeutic Vaccines Sales by Type (2020-2025) & (k units)
- Table 88. Global Therapeutic Vaccines Sales by Type (2026-2031) & (k units)
- Table 89. Global Therapeutic Vaccines Sales Market Share by Type (2020-2025)
- Table 90. Global Therapeutic Vaccines Sales Market Share by Type (2026-2031)
- Table 91. Global Therapeutic Vaccines Revenue by Type (2020-2025) & (US$ Million)
- Table 92. Global Therapeutic Vaccines Revenue by Type (2026-2031) & (US$ Million)
- Table 93. Global Therapeutic Vaccines Revenue Market Share by Type (2020-2025)
- Table 94. Global Therapeutic Vaccines Revenue Market Share by Type (2026-2031)
- Table 95. Global Therapeutic Vaccines Price by Type (2020-2025) & (US$/unit)
- Table 96. Global Therapeutic Vaccines Price by Type (2026-2031) & (US$/unit)
- Table 97. Global Therapeutic Vaccines Sales by Application (2020-2025) & (k units)
- Table 98. Global Therapeutic Vaccines Sales by Application (2026-2031) & (k units)
- Table 99. Global Therapeutic Vaccines Sales Market Share by Application (2020-2025)
- Table 100. Global Therapeutic Vaccines Sales Market Share by Application (2026-2031)
- Table 101. Global Therapeutic Vaccines Revenue by Application (2020-2025) & (US$ Million)
- Table 102. Global Therapeutic Vaccines Revenue by Application (2026-2031) & (US$ Million)
- Table 103. Global Therapeutic Vaccines Revenue Market Share by Application (2020-2025)
- Table 104. Global Therapeutic Vaccines Revenue Market Share by Application (2026-2031)
- Table 105. Global Therapeutic Vaccines Price by Application (2020-2025) & (US$/unit)
- Table 106. Global Therapeutic Vaccines Price by Application (2026-2031) & (US$/unit)
- Table 107. Key Raw Materials
- Table 108. Raw Materials Key Suppliers
- Table 109. Therapeutic Vaccines Distributors List
- Table 110. Therapeutic Vaccines Customers List
- Table 111. Therapeutic Vaccines Industry Trends
- Table 112. Therapeutic Vaccines Industry Drivers
- Table 113. Therapeutic Vaccines Industry Restraints
- Table 114. Authors List of This Report
- List of Figures
- Figure 1. Research Methodology
- Figure 2. Research Process
- Figure 3. Key Executives Interviewed
- Figure 4. Therapeutic Vaccines Product Image
- Figure 5. Global Therapeutic Vaccines Revenue (US$ Million), 2020 VS 2024 VS 2031
- Figure 6. Global Therapeutic Vaccines Market Size (2020-2031) & (US$ Million)
- Figure 7. Global Therapeutic Vaccines Sales (2020-2031) & (k units)
- Figure 8. Global Therapeutic Vaccines Average Price (US$/unit) & (2020-2031)
- Figure 9. Nucleic Acid Therapeutic Vaccine Product Image
- Figure 10. Peptide Therapeutic Vaccine Product Image
- Figure 11. Cell Therapeutic Vaccine Product Image
- Figure 12. Oncotherapy Product Image
- Figure 13. Hepatitis B Product Image
- Figure 14. Tuberculosis Product Image
- Figure 15. Herpes Simplex Virus Product Image
- Figure 16. Others Product Image
- Figure 17. Global Therapeutic Vaccines Revenue Share by Manufacturers in 2024
- Figure 18. Global Manufacturers of Therapeutic Vaccines, Manufacturing Sites & Headquarters
- Figure 19. Global Top 5 and 10 Therapeutic Vaccines Players Market Share by Revenue in 2024
- Figure 20. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
- Figure 21. Global Therapeutic Vaccines Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
- Figure 22. Global Therapeutic Vaccines Sales by Region in 2024
- Figure 23. Global Therapeutic Vaccines Revenue by Region in 2024
- Figure 24. North America Therapeutic Vaccines Market Size by Country in 2024
- Figure 25. North America Therapeutic Vaccines Sales Market Share by Country (2020-2031)
- Figure 26. North America Therapeutic Vaccines Revenue Market Share by Country (2020-2031)
- Figure 27. United States Therapeutic Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 28. Canada Therapeutic Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 29. Europe Therapeutic Vaccines Market Size by Country in 2024
- Figure 30. Europe Therapeutic Vaccines Sales Market Share by Country (2020-2031)
- Figure 31. Europe Therapeutic Vaccines Revenue Market Share by Country (2020-2031)
- Figure 32. Germany Therapeutic Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 33. France Therapeutic Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 34. U.K. Therapeutic Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 35. Italy Therapeutic Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 36. Netherlands Therapeutic Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 37. Asia Pacific Therapeutic Vaccines Market Size by Country in 2024
- Figure 38. Asia Pacific Therapeutic Vaccines Sales Market Share by Country (2020-2031)
- Figure 39. Asia Pacific Therapeutic Vaccines Revenue Market Share by Country (2020-2031)
- Figure 40. China Therapeutic Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 41. Japan Therapeutic Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 42. South Korea Therapeutic Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 43. India Therapeutic Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 44. Australia Therapeutic Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 45. China Taiwan Therapeutic Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 46. Southeast Asia Therapeutic Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 47. Southeast Asia Therapeutic Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 48. South America Therapeutic Vaccines Market Size by Country in 2024
- Figure 49. South America Therapeutic Vaccines Sales Market Share by Country (2020-2031)
- Figure 50. South America Therapeutic Vaccines Revenue Market Share by Country (2020-2031)
- Figure 51. Mexico Therapeutic Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 52. Brazil Therapeutic Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 53. Argentina Therapeutic Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 54. Colombia Therapeutic Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 55. Middle East and Africa Therapeutic Vaccines Market Size by Country in 2024
- Figure 56. Middle East and Africa Therapeutic Vaccines Sales Market Share by Country (2020-2031)
- Figure 57. Middle East and Africa Therapeutic Vaccines Revenue Market Share by Country (2020-2031)
- Figure 58. Turkey Therapeutic Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 59. Saudi Arabia Therapeutic Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 60. UAE Therapeutic Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 61. Global Therapeutic Vaccines Sales Market Share by Type (2020-2031)
- Figure 62. Global Therapeutic Vaccines Revenue Market Share by Type (2020-2031)
- Figure 63. Global Therapeutic Vaccines Price (US$/unit) by Type (2020-2031)
- Figure 64. Global Therapeutic Vaccines Sales Market Share by Application (2020-2031)
- Figure 65. Global Therapeutic Vaccines Revenue Market Share by Application (2020-2031)
- Figure 66. Global Therapeutic Vaccines Price (US$/unit) by Application (2020-2031)
- Figure 67. Therapeutic Vaccines Value Chain
- Figure 68. Therapeutic Vaccines Production Mode & Process
- Figure 69. Direct Comparison with Distribution Share
- Figure 70. Distributors Profiles
- Figure 71. Therapeutic Vaccines Industry Opportunities and Challenges
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.


